Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Rivaroxaban MCP | Med city | Film-coated tablet | Jan 1, 2024 | Generic |
| VERKAZIA | Excelvision | Eye drops, emulsion | Jan 1, 2024 | NCE |
| Haegarda | CSL BEHRING | Powder and solvent for solution for injection | Jan 1, 2024 | Biological |
| Trumavar | Natco Pharma Limited | Film-coated tablet | Jan 1, 2024 | Generic |
| Haegarda | CSL BEHRING | Powder and solvent for solution for injection | Jan 1, 2024 | Biological |
| Tenival | Macleods Pharmaceuticals Limited | Film-coated tablet | Jan 1, 2024 | Generic |
| Ataben | Hetero Labs Limited Unit – III | Capsule, hard | Jan 1, 2024 | Generic |
| Tenival | Macleods Pharmaceuticals Limited | Film-coated tablet | Jan 1, 2024 | Generic |
| Ravopro | RAFARM S.A | Eye drops | Jan 1, 2024 | Generic |
| Trumavar | Natco Pharma Limited | Film-coated tablet | Jan 1, 2024 | Generic |
| Lammalid | Synthon Chile LTDA | Capsule, hard | Jan 1, 2024 | Generic |
| Lammalid | Synthon Chile LTDA | Capsule, hard | Jan 1, 2024 | Generic |
| Propylthiouracil MACLEODS | Macleods Pharmaceuticals Ltd. | Tablet | Jan 1, 2024 | Generic |
| Jaypirca | ELI LILLY | Tablet | Jan 1, 2024 | NCE |
| Vtreat | PHARMATHEN INTERNATIONAL | Tablet | Jan 1, 2024 | Generic |
| Lammalid | Synthon Chile LTDA | Capsule, hard | Jan 1, 2024 | Generic |
| Jaypirca | ELI LILLY | Tablet | Jan 1, 2024 | NCE |
| Arify | Alrai Pharmaceutical industry Co. (L.L.C) | Tablet | Jan 1, 2024 | Generic |
| Warfarin Macleods | Macleods Pharmaceuticals Ltd. | Tablet | Jan 1, 2024 | Generic |
| Jaypirca | ELI LILLY | Tablet | Jan 1, 2024 | NCE |
